Patient-Reported Outcomes And Quality Of Life In Alta: The Randomized Phase 2 Study Of Brigatinib (Brg) In Advanced Alk Plus Non-Small Cell Lung Cancer (Nsclc).
JOURNAL OF CLINICAL ONCOLOGY(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2017)